help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on April 5, 2007
Endocrinology, doi:10.1210/en.2006-1580
A more recent version of this article appeared on July 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
148/7/3164    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Latif, R.
Right arrow Articles by Davies, T. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Latif, R.
Right arrow Articles by Davies, T. F.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL

Submitted on November 27, 2006
Accepted on March 26, 2007

LIPID RAFTS ARE TRIAGE CENTERS FOR MULTIMERIC AND MONOMERIC TSH RECEPTOR REGULATION

R. Latif*, T. Ando, and T. F. Davies

Division of Endocrinology and Metabolism, James J Peters VA Medical Center, Mount Sinai School of Medicine, New York, New York. And University of Nagasaki, Nagasaki, Japan

* To whom correspondence should be addressed. E-mail: rauf.latif{at}mssm.edu.

The TSH receptor (TSHR), a heptahelical G protein coupled receptor on the surface of thyrocytes, is a major autoantigen and physiologic regulator of the thyroid gland. Unlike other G protein coupled receptors (GPCRs), the TSHR undergoes post-translational cleavage of its ectodomain leading to the existence of several forms of the receptor on the plasma membrane. We previously hypothesized that in order to achieve high fidelity and specificity of TSH ligand or TSHR-autoantibody signaling, the TSHR may compartmentalize into microdomains within the plasma membrane. In support of this hypothesis we have shown previously that TSHRs reside in GM1 enriched lipid rafts in the plasma membrane of TSHR expressing cells. In this study, we further explore the different forms of TSH receptors which reside in lipid rafts. We studied both TSHR transfected cells and rat thyrocytes, using both non-detergent biochemical analyses and receptor-lipid raft co-localization. Using the biochemical approach we observed that monomeric receptors existed in both raft and non-raft fractions of the cell surface in the steady state. We also demonstrated that the multimeric forms of the receptor were preferentially partitioned into the lipid microdomains. Different TSHR forms, including multimers, were dynamically regulated both by receptor specific and post receptor specific modulators. TSH ligand and TSHR-antibody of the stimulating variety induced decrease of multimeric forms in the raft fractions. In addition, multimeric and monomeric forms of the receptor were both associated with Gs{alpha} within and outside of the rafts. Although failure to achieve total lipid raft disruption prevented a conclusion regarding the relative power of TSHR signaling within and without the raft domains, these data showed clearly that not only were a significant proportion of TSHRs residing within lipid microdomains but that constitutive multimerization of TSHRs was actually regulated within the lipid rafts.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society